Anthrax News and Research

RSS
Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Anthrax most commonly occurs in wild and domestic lower vertebrates (cattle, sheep, goats, camels, antelopes, and other herbivores), but it can also occur in humans when they are exposed to infected animals or tissue from infected animals.

Anthrax is most common in agricultural regions where it occurs in animals. These include South and Central America, Southern and Eastern Europe, Asia, Africa, the Caribbean, and the Middle East. When anthrax affects humans, it is usually due to an occupational exposure to infected animals or their products. Workers who are exposed to dead animals and animal products from other countries where anthrax is more common may become infected with B. anthracis (industrial anthrax). Anthrax outbreaks occur in the United States on an annual basis in livestock and wild game animals such as deer.

Anthrax infection can occur in three forms: cutaneous (skin), inhalation, and gastrointestinal. B. anthracis spores can live in the soil for many years, and humans can become infected with anthrax by handling products from infected animals or by inhaling anthrax spores from contaminated animal products. Anthrax can also be spread by eating undercooked meat from infected animals. It is rare to find infected animals in the United States.
FDA grants orphan drug designation for Aradigm's ciprofloxacin to manage bronchiectasis

FDA grants orphan drug designation for Aradigm's ciprofloxacin to manage bronchiectasis

Emergent in active discussions with U.S. government for multi-year supply of BioThrax to the SNS

Emergent in active discussions with U.S. government for multi-year supply of BioThrax to the SNS

PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings

PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings

TFAH warns about impact of CDC budget cuts on America's future health

TFAH warns about impact of CDC budget cuts on America's future health

Response Biomedical first quarter total revenues increase 59% to $2,470,560

Response Biomedical first quarter total revenues increase 59% to $2,470,560

UCF to develop safe, inexpensive and effective polio vaccine

UCF to develop safe, inexpensive and effective polio vaccine

UIC receives federal contract to develop antibiotics against three bacterial infections

UIC receives federal contract to develop antibiotics against three bacterial infections

AquaStar granted U.S. Patent for Portable Capillary Sensor technology used in Capwave ELISA platform

AquaStar granted U.S. Patent for Portable Capillary Sensor technology used in Capwave ELISA platform

IQ Therapeutics completes dosing in IQNLF Phase I trial for anthrax

IQ Therapeutics completes dosing in IQNLF Phase I trial for anthrax

Magnetic 'nanobeads' help detect chemical and biological agents

Magnetic 'nanobeads' help detect chemical and biological agents

PolyMedix defensin-mimetic antibiotic compounds show antimicrobial efficacy against anthrax

PolyMedix defensin-mimetic antibiotic compounds show antimicrobial efficacy against anthrax

Aradigm fourth quarter revenue is $144,000 for 2010

Aradigm fourth quarter revenue is $144,000 for 2010

Enrollment complete in Aradigm's inhaled ciprofloxacin Phase 2b study in non-cystic fibrosis bronchiectasis

Enrollment complete in Aradigm's inhaled ciprofloxacin Phase 2b study in non-cystic fibrosis bronchiectasis

Cangene second quarter revenues increase 3% to $40.2 million

Cangene second quarter revenues increase 3% to $40.2 million

Response Biomedical 2010 total revenues decrease to $7,610,827

Response Biomedical 2010 total revenues decrease to $7,610,827

Illicit drug users may face increased risk of microbial infections

Illicit drug users may face increased risk of microbial infections

Institute for Genome Sciences plays key role in investigation of anthrax attacks

Institute for Genome Sciences plays key role in investigation of anthrax attacks

New review of anthrax case discussed by review committee vice chair, Stanford bioterrorism expert

New review of anthrax case discussed by review committee vice chair, Stanford bioterrorism expert

TFAH applauds overall increase in disease prevention funding, expresses concern over CDC cuts

TFAH applauds overall increase in disease prevention funding, expresses concern over CDC cuts

Abbott's Ibis, PLEX-ID technologies identify causative organism of plague in Afghanistan

Abbott's Ibis, PLEX-ID technologies identify causative organism of plague in Afghanistan

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.